Redwoods Acquisition (RWOD) Short Interest Ratio & Short Volume

Short interest is the volume of Redwoods Acquisition shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 34,500 shares of RWOD short. 2.05% of Redwoods Acquisition's shares are currently sold short. Learn More on Redwoods Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.05% of Redwoods Acquisition's floating shares are currently sold short.

Redwoods Acquisition saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 34,500 shares, a drop of 36.9% from the previous total of 54,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Redwoods Acquisition currently has issued a total of 5,165,000 shares. Some of Redwoods Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Redwoods Acquisition currently has a public float of 1,680,000 shares.

2.05% of Redwoods Acquisition's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Redwoods Acquisition: IN8bio, Inc. (3.12%), NRx Pharmaceuticals, Inc. (8.64%), Kazia Therapeutics Limited (0.71%), PharmaCyte Biotech, Inc. (0.87%), Sol-Gel Technologies Ltd. (0.39%), NLS Pharmaceutics Ltd. (1.27%), ANEW Medical, Inc. (1.67%), Sensei Biotherapeutics, Inc. (1.18%), Aspira Women's Health Inc. (4.86%), Talphera, Inc. (0.60%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

Short selling RWOD is an investing strategy that aims to generate trading profit from Redwoods Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Redwoods Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RWOD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RWOD, twice per month. The most recent reporting period available is May, 31 2024.